Can a cancer pill stall eye tumor spread? new study reveals results
NCT ID NCT02517736
First seen Feb 18, 2026 · Last updated May 10, 2026 · Updated 16 times
Summary
This study tested the drug sorafenib (Nexavar) in 32 adults with uveal melanoma that had spread to other parts of the body. The main goal was to see if the drug could stop tumors from growing for at least 24 weeks. Researchers also watched for side effects. The trial is now complete, and results help understand if this treatment can help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEAL MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service d'ophtalmologie, CHU de Caen
Caen, 14000, France
Conditions
Explore the condition pages connected to this study.